Wednesday 4th April 2012
|Text too small?|
Ecoya, the scented candle and skin-care products maker, has beaten its forecast annual sales by 10 percent.
Annual revenue was about $22 million, beating the $20 million forecast affirmed in its first-half report, according to a statement from the Auckland-based company.
It made no mention of annual profit, after breaking even on a pretax earnings basis in the first half, when it indicated it should be in the black by the end of the financial year. Ecoya’s financial statements are being audited at the moment, and it expects to publish the final result at the end of May.
Last week, the company completed its acquisition of the Trilogy skin-care business, making a final payment of $9.2 million in cash and scrip after meeting earn-out targets.
The stock was unchanged at 95 cents today, and is up 1.1 percent this year.
No comments yet
Ecoya ekes out small annual profit, EBITDA up 26%
Ecoya changes name to Trilogy as skincare range trumps scented candles
Ecoya beats 2013 earnings guidance as Trilogy dominates
Ecoya posts maiden annual operating profit
Ecoya signs deal with Japanese distributor
Sam Morgan, David Wright increase stake in Ecoya; Rob Fyfe buys shares from founder
Ecoya on track for 2012 profit, breaks even at EBIT level in first half
Ecoya is confident of achieving revenue forecast
UPDATED: Ecoya completes $4.7m share placement
Ecoya shares halted for share placement